Institutional
Propel Bio Management, LLC
CIK 0001969764
$158.7M
Reported AUM
38
Positions
Q1 2026
Period
2026-05-14
Filed
The Brief · Propel Bio Management, LLC · Q1 2026
AI · grounded in 13F
Propel Bio Management, LLC established a new position in CORT worth $6.02M. The fund also opened new stakes in VOR for $5.59M and OBIO for $3.83M. On the sell side, the manager closed its position in NKTR, reducing exposure by $3.5M.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PAGP | PLAINS GP HLDGS L P | $24.46 | -1.33% | 42.49% | 236.18% | $30.2M | 19.02% | — | HELD |
| 2 | ACHV | ACHIEVE LIFE SCIENCES INC | $5.48 | 6.83% | 33.94% | -29.82% | $11.4M | 7.17% | — | HELD |
| 3 | PHAT | PHATHOM PHARMACEUTICALS INC | $10.06 | -0.69% | 13.57% | -68.44% | $9.4M | 5.90% | +100,354 | +13.5% |
| 4 | DCTH | DELCATH SYS INC | $10.67 | -1.11% | -34.86% | 4.61% | $9.2M | 5.77% | +541,189 | +123.4% |
| 5 | CORT | CORCEPT THERAPEUTICS INC | $73.99 | 1.89% | 4.34% | 249.64% | $6.0M | 3.80% | +147,828 | NEW |
| 6 | ABEO | ABEONA THERAPEUTICS INC | $5.46 | -6.19% | -18.99% | -82.10% | $6.0M | 3.79% | +499,119 | +60.1% |
| 7 | VOR | VOR BIOPHARMA INC | $13.16 | -8.10% | 193.75% | -94.74% | $5.6M | 3.52% | +314,543 | NEW |
| 8 | KYTX | KYVERNA THERAPEUTICS INC | $7.52 | 0.66% | 120.35% | -69.93% | $5.6M | 3.52% | −22,245 | −3.3% |
| 9 | MIST | MILESTONE PHARMACEUTICALS IN | $1.23 | -4.65% | -28.90% | -78.42% | $5.1M | 3.20% | — | HELD |
| 10 | CLDX | CELLDEX THERAPEUTICS INC NEW | $28.77 | 0.54% | 34.05% | -34.58% | $4.1M | 2.61% | −22,936 | −14.9% |
| 11 | CMPS | COMPASS PATHWAYS PLC | $11.70 | -3.39% | 152.29% | -65.87% | $4.1M | 2.60% | −119,729 | −13.9% |
| 12 | VRDN | VIRIDIAN THERAPEUTICS INC | $15.78 | -4.77% | 7.49% | 1.64% | $4.1M | 2.58% | −72,368 | −25.6% |
| 13 | IVA | INVENTIVA SA | $4.03 | -4.73% | 11.79% | -70.01% | $4.0M | 2.52% | −275,322 | −27.5% |
| 14 | SABS | SAB BIOTHERAPEUTICS INC | $3.38 | 0.00% | 86.74% | -96.59% | $3.9M | 2.45% | +359,909 | +55.1% |
| 15 | OBIO | ORCHESTRA BIOMED HLDGS INC | $4.00 | 2.56% | 29.45% | -59.64% | $3.8M | 2.41% | +896,701 | NEW |
| 16 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $8.64 | -13.69% | 98.62% | -65.26% | $3.6M | 2.26% | +380,420 | NEW |
| 17 | OCS | OCULIS HOLDING AG | $10.78 | -3.84% | -43.72% | 16.05% | $3.3M | 2.07% | −50,616 | −29.3% |
| 18 | OCUL | OCULAR THERAPEUTIX INC | $8.25 | -6.25% | -8.54% | -25.07% | $3.2M | 2.03% | +382,375 | NEW |
| 19 | UPB | UPSTREAM BIO INC | $7.05 | -5.11% | -37.44% | -67.76% | $3.1M | 1.95% | +341,779 | NEW |
| 20 | AQST | AQUESTIVE THERAPEUTICS INC | $3.90 | -0.64% | 10.39% | 20.92% | $3.0M | 1.86% | +710,988 | NEW |
| 21 | EYPT | EYEPOINT INC | $11.64 | -1.19% | 31.77% | 43.31% | $2.8M | 1.76% | +215,825 | NEW |
| 22 | TRVI | TREVI THERAPEUTICS INC | $13.33 | -4.31% | 88.81% | 601.58% | $2.6M | 1.67% | +223,802 | NEW |
| 23 | ZVRA | ZEVRA THERAPEUTICS INC | $10.61 | -5.01% | 14.58% | 5.15% | $2.6M | 1.66% | +218,735 | +343.5% |
| 24 | VTLUSD | IMMUNIC INC | — | — | — | — | $2.6M | 1.65% | +2,344,779 | NEW |
| 25 | CHRS | COHERUS ONCOLOGY INC | $1.45 | -7.94% | 74.70% | -88.89% | $2.4M | 1.52% | +1,420,550 | NEW |
| 26 | OVID | OVID THERAPEUTICS INC | $2.40 | -3.23% | 652.35% | -35.66% | $2.0M | 1.28% | +921,457 | NEW |
| 27 | PALI | PALISADE BIO INC | $1.74 | -9.84% | 148.57% | -99.92% | $2.0M | 1.26% | +1,115,000 | NEW |
| 28 | KLRS | KALARIS THERAPEUTICS INC | $4.44 | -4.72% | 34.55% | -98.99% | $1.7M | 1.08% | +253,718 | +603.3% |
| 29 | QURE | UNIQURE NV | $26.45 | -5.50% | 53.16% | -8.82% | $1.7M | 1.08% | +104,772 | NEW |
| 30 | LONA | LEONABIO INC | $8.22 | -4.53% | 128.33% | -91.45% | $1.5M | 0.94% | — | HELD |
| 31 | NUVB | NUVATION BIO INC | $4.82 | -6.77% | — | — | $1.4M | 0.89% | +329,296 | NEW |
| 32 | MAZE | MAZE THERAPEUTICS INC | $24.27 | -4.45% | — | — | $1.3M | 0.82% | +43,798 | NEW |
| 33 | EVMN | EVOMMUNE INC | $19.51 | -2.03% | — | — | $1.3M | 0.81% | +55,664 | NEW |
| 34 | CRVS | CORVUS PHARMACEUTICALS INC | $11.23 | 0.99% | — | — | $1.3M | 0.79% | +85,791 | NEW |
| 35 | ALDX | ALDEYRA THERAPEUTICS INC | $1.63 | -7.39% | — | — | $1.2M | 0.78% | +730,606 | NEW |
| 36 | ARTV | ARTIVA BIOTHERAPEUTICS INC | $6.81 | -0.60% | — | — | $950K | 0.60% | +146,369 | NEW |
| 37 | CNTB | CONNECT BIOPHARMA HLDGS LTD | $2.17 | -5.65% | — | — | $554K | 0.35% | +209,493 | NEW |
| 38 | MSLE | SATELLOS BIOSCIENCE INC | $5.62 | -6.49% | — | — | $57K | 0.04% | +10,145 | NEW |
| 39 | NKTR | NEKTAR THERAPEUTICS | $56.04 | -2.23% | — | — | — | — | −82,822 | EXITED |
| 40 | RGNX | REGENXBIO INC | $6.03 | -0.82% | — | — | — | — | −116,896 | EXITED |
| 41 | LENZ | LENZ THERAPEUTICS INC | $6.94 | -1.00% | — | — | — | — | −59,085 | EXITED |
| 42 | AARD | AARDVARK THERAPEUTICS INC | $3.68 | -6.60% | — | — | — | — | −46,408 | EXITED |
Source: SEC EDGAR · accession 0000898432-26-000369. 13F discloses long positions only — shorts, foreign equities, and options are excluded.